Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Days Payable : 101.34 (As of Mar. 2025)

View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Days Payable?

Zhongyuan Union Cell & Gene Engineering's average Accounts Payable for the three months ended in Mar. 2025 was ¥123 Mil. Zhongyuan Union Cell & Gene Engineering's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥111 Mil. Hence, Zhongyuan Union Cell & Gene Engineering's Days Payable for the three months ended in Mar. 2025 was 101.34.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's Days Payable or its related term are showing as below:

SHSE:600645' s Days Payable Range Over the Past 10 Years
Min: 46.85 Med: 58.56 Max: 84.76
Current: 84.76

During the past 13 years, Zhongyuan Union Cell & Gene Engineering's highest Days Payable was 84.76. The lowest was 46.85. And the median was 58.56.

SHSE:600645's Days Payable is ranked worse than
58.78% of 706 companies
in the Biotechnology industry
Industry Median: 118.245 vs SHSE:600645: 84.76

Zhongyuan Union Cell & Gene Engineering's Days Payable increased from Mar. 2024 (82.47) to Mar. 2025 (101.34). It may suggest that Zhongyuan Union Cell & Gene Engineering delayed paying its suppliers.

Zhongyuan Union Cell & Gene Engineering Days Payable Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Days Payable Chart

Zhongyuan Union Cell & Gene Engineering Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

63.87

59.05

63.42

81.15

85.26

Zhongyuan Union Cell & Gene Engineering Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Payable	Get a 7-Day Free Trial															82.47	83.42	93.00	85.16	101.34

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's Days Payable

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhongyuan Union Cell & Gene Engineering's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Days Payable distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Days Payable falls into.

Save Embed

;

Save Embed

;

Zhongyuan Union Cell & Gene Engineering Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zhongyuan Union Cell & Gene Engineering's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (113.35	+	114.507)	/	2 )	/	487.742	*	365
=	113.9285					/	487.742	*	365
=	85.26

Zhongyuan Union Cell & Gene Engineering's Days Payable for the quarter that ended in Mar. 2025 is calculated as:

	Days Payable (Q: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2024 )	+	Accounts Payable (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (114.507	+	132.375)	/	2 )	/	111.146	*	365 / 4
=	123.441					/	111.146	*	365 / 4
=	101.34

Zhongyuan Union Cell & Gene Engineering Days Payable Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongyuan Union Cell & Gene Engineering Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304

Website

http://www.vcanbio.com

Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.

Executives

Li De Fu	Director
Wang Xue Jun	senior management
Wang Yong	Director
Li Hai Bin	Director
He Wei	senior management
Li Qiang	senior management
Wu Ming Yuan	Director
Wang Hui	Director
Huang Jia Xue	senior management
Cao Hai Feng	Director
Han Yue E	Director
Liu Yong Jun	senior management
Cui Jing Xue	Supervisors
Yang Guang Xing	senior management
Meng Zhi Hong	senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines